L-gulonolactone oxidase (GULO) is an enzyme that is essential for the synthesis of L-ascorbic acid (Vitamin C) in most mammals . GULO belongs to the family of aldonolactone oxidoreductases (AlORs) and contains two conserved domains: an N-terminal FAD-binding region and a C-terminal HWXK motif capable of binding the flavin cofactor . Humans and guinea pigs cannot synthesize Vitamin C due to mutations in the GULO gene, which have led to its pseudogenization (the conversion of a functional gene into a non-functional pseudogene) .
Recombinant GULO refers to GULO that is produced using recombinant DNA technology, where the GULO gene from one organism (in this case, a pig) is expressed in a different host organism (e.g., bacteria, yeast, or mammalian cells) to produce the enzyme . The recombinant form of GULO can be used for research purposes, such as studying its enzymatic activity, structure, and potential applications in biotechnology and medicine .
Recombinant GULO can be produced in various expression systems, each with its own advantages and challenges .
The enzymatic activity of recombinant GULO can be assessed using various methods, including GULO activity assays and in-gel staining for GULO activity . These assays measure the rate at which GULO catalyzes the conversion of L-gulono-γ-lactone to L-ascorbic acid .
Factors Affecting Enzyme Activity:
pH: The optimal pH for GULO activity varies depending on the source of the enzyme. For example, the optimal activities of recombinant full-length rat GULO (fGULO) and its C-terminal catalytic domain (cGULO) were observed at pH 7 and 6.5, respectively . The enzymatic activity of GULO generally increases in the acidic range of pH 3.0 to 6.0 and decreases in the alkaline range of pH 7.5 to 9.5 .
Temperature: The optimal temperature for GULO activity also varies. The optimal temperatures for fGULO and cGULO were found to be 40 °C and 30 °C, respectively .
Substrate Concentration: Kinetic studies have shown that the Michaelis constant () values for fGULO and cGULO at low substrate concentrations were 53.5 ± 5 µM and 42 ± 6.3 µM, respectively .
Recombinant GULO has several potential applications in research, biotechnology, and medicine:
Vitamin C Production: Recombinant GULO can be used to produce Vitamin C in vitro or in vivo . For example, expressing murine Gulo in human cells can rescue the Vitamin C biosynthesis pathway .
Gene Therapy: Adenoviral vectors expressing murine Gulo have been used to increase serum Vitamin C levels in Gulo knockout mice, which are unable to synthesize Vitamin C .
Transgenic Animal Models: Ongoing research focuses on using lentivirus vectors to express murine Gulo in guinea pigs, which, like humans, cannot synthesize Vitamin C. This approach has been shown to extend the lives of guinea pigs maintained on a Vitamin C-free diet .
Understanding GULO Function: Creating recombinant versions of GULO allows scientists to study the structure, function, and regulation of GULO in more detail .
| Code | Source | Conjugate |
|---|---|---|
| CSB-YP811552PI1 | Yeast | N/A |
| CSB-EP811552PI1 | E. coli | N/A |
| CSB-EP811552PI1-B | E. coli | Avi-tag Biotinylated (E. coli biotin ligase (BirA) is highly specific in covalently attaching biotin to the 15 amino acid AviTag peptide. This recombinant protein was biotinylated in vivo by AviTag-BirA technology, which method is BriA catalyzes amide linkage between the biotin and the specific lysine of the AviTag.) |
| CSB-BP811552PI1 | Baculovirus | N/A |
| CSB-MP811552PI1 | Mammalian cell | N/A |
L-gulonolactone oxidase (GULO) is an enzyme that catalyzes the final step in L-ascorbic acid (vitamin C) biosynthesis. This enzymatic activity has been lost in primates, including humans, necessitating dietary intake of vitamin C to prevent scurvy. The significance of GULO lies in understanding evolutionary patterns of gene degradation and metabolic pathway losses across species. Loss of the vitamin C pathway due to deletions in the GULO gene has been detected in humans, apes, guinea pigs, bats, mice, rats, pigs, and passerine birds, making it an important model for studying genetic entropy and evolutionary biology .
Methodologically, comparative genomic analysis of GULO genes and pseudogenes across species requires careful sequence alignment techniques, consideration of transposable element fragments that may contribute to deletion events, and phylogenetic analysis to determine independent versus shared mutation events.
Porcine GULO shares structural and functional similarities with GULO from other mammals, but with species-specific variations. While complete structural characterization of pig GULO has not been fully documented in the provided literature, research on rat GULO variants offers valuable comparative insights.
Studies on rat GULO have demonstrated that both full-length (fGULO) and C-terminal catalytic domain (cGULO) variants maintain biological activity. The C-terminal domain appears to be the primary catalytic region, with optimal activities observed at specific pH and temperature conditions (pH 7.0 and 40°C for fGULO; pH 6.5 and 30°C for cGULO) . Similar domain organization would be expected in porcine GULO.
From an experimental perspective, researchers should consider that while pigs naturally express functional GULO (unlike humans), recombinant expression allows for protein engineering, improvement of catalytic properties, and detailed structure-function analysis.
Advantages: Cost-effective, high yield, rapid production
Limitations: Potential misfolding, lack of post-translational modifications
Example: E. coli has been successfully used to produce both full-length rat GULO and its C-terminal catalytic domain
Advantages: Proper protein folding and post-translational modifications
Limitations: Higher cost, slower production, lower yield
Advantages: Scalability, proper folding, cost-effectiveness for large-scale production
Limitations: Longer production time, potential glycosylation differences
When selecting an expression system, researchers should consider that the C-terminal catalytic domain of GULO appears to be more efficiently produced in bacterial systems than the full-length protein, which may inform construct design strategies for pig GULO expression .
GULO activity can be assessed using several established protocols, with adaptations required for recombinant pig GULO analysis:
Prepare reaction mixture containing:
50 mM potassium phosphate buffer (pH 7.0)
50 mM sodium citrate
1 mM dithiothreitol
10 μM FAD
Recombinant GULO enzyme
Initiate reaction by adding 2.5 mM L-gulono-γ-lactone as substrate
Incubate under aerobic conditions at 37°C with vigorous shaking for 15 minutes
Terminate reaction with trichloroacetic acid (final concentration 5%)
In-gel Activity Staining:
This complementary approach allows visualization of GULO activity directly within a native polyacrylamide gel, providing information about enzyme integrity and oligomeric state simultaneously with activity.
When conducting these assays, it is critical to include appropriate controls, such as samples without substrate or enzyme, to account for background reactions. Researchers should also consider optimizing reaction conditions specifically for pig GULO, as optimal temperatures and pH may differ from the rat enzyme parameters (pH 7.0, 40°C for fGULO; pH 6.5, 30°C for cGULO) .
Modern genetic engineering of pig GULO can be accomplished through several approaches, with CRISPR/Cas9 emerging as the most efficient method:
Design guide RNAs (gRNAs) targeting specific regions of the pig GULO gene
Introduce CRISPR/Cas9 components along with donor DNA templates (if performing knockin)
Screen for successful edits using PCR, sequencing, or functional assays
Generate founder animals through embryo modification or somatic cell nuclear transfer (SCNT)
Modify pig fibroblasts using CRISPR/Cas9 or other gene editing techniques
Replace nuclei in porcine oocytes with nuclei from modified fibroblasts
Develop reconstructed embryos and transfer to surrogate sows
Screen resulting offspring for desired genetic modifications
The efficiency of GULO modification can be enhanced by:
Using multiple gRNAs to target different GULO exons simultaneously
Employing homology-directed repair for precise modifications
Screening large numbers of edited cells before SCNT to increase success rates
For researchers studying GULO function, conditional knockout systems may be preferable to complete gene deletion, allowing for temporal control of GULO expression and avoiding complications from complete vitamin C deficiency in the animals.
Purification of recombinant pig GULO requires careful consideration of protein structure and biochemical properties. Based on studies with rat GULO, the following strategies are recommended:
His-tag purification has been successfully employed for both full-length and C-terminal domain variants of rat GULO
Careful buffer optimization is essential to maintain FAD cofactor association and enzyme activity
Initial capture using affinity chromatography (e.g., His-tag)
Intermediate purification via ion exchange chromatography
Polishing step using size exclusion chromatography to ensure homogeneity
Maintain reducing conditions throughout purification to protect critical thiol groups
Include FAD in buffers to prevent cofactor dissociation
Monitor activity at each purification step to track yield and specific activity
Consider using the C-terminal catalytic domain for higher expression efficiency and easier purification
Researchers should note that protein yield and specific activity data from rat GULO studies suggest that the C-terminal domain may be advantageous for applications requiring larger amounts of purified enzyme.
Recombinant pig GULO has potential applications in xenotransplantation research, particularly in creating genetically modified pigs for organ donation to humans:
Since humans lack functional GULO, pig organs expressing GULO could potentially provide local vitamin C production in the transplanted organ
This could enhance tissue resilience through antioxidant protection during the stressful transplantation process
Integration with Other Genetic Modifications:
Optimal xenotransplantation organ-source pigs typically require multiple genetic modifications, including:
Deletion of xenoantigens (e.g., GTKO, β4GalNT2KO, CMAHKO)
Addition of human complement-regulatory proteins
GULO expression or modification could be incorporated into these multi-gene-edited pigs through CRISPR/Cas9 technology with SCNT . When designing such experiments, researchers should consider potential interactions between GULO expression and other genetic modifications, particularly those affecting immune and inflammatory responses.
Maintaining GULO activity presents several challenges due to the enzyme's biochemical properties:
GULO requires FAD as a cofactor for activity
Protocols should include FAD supplementation during purification and storage
Monitor FAD:protein ratio spectrophotometrically
As an oxidase, GULO is ironically sensitive to oxidative damage
Storage buffers should include reducing agents (e.g., DTT, β-mercaptoethanol)
Consider adding glycerol (20-30%) to prevent freeze-thaw damage
Temperature Stability:
Based on rat GULO studies, the enzyme exhibits temperature-dependent activity profiles:
These temperature profiles suggest differences in structural stability that should inform storage conditions and experimental design.
Site-directed mutagenesis to enhance thermostability
Formulation optimization (pH, ionic strength, excipients)
Protein engineering to create more stable variants
Immobilization on solid supports for specific applications
Researchers should systematically evaluate these factors when working with recombinant pig GULO to ensure consistent enzyme performance across experiments.
Studying recombinant pig GULO offers valuable comparative insights for human GULO pseudogene research:
Humans possess a GULO pseudogene with multiple exon losses
Comparative analysis of functional pig GULO with the human pseudogene can reveal the molecular basis for vitamin C synthesis loss in primates
Research suggests that GULO exon losses in humans, chimpanzees, and gorillas occurred independently, not supporting simple common ancestry models
Recombinant pig GULO allows structure-function studies not possible with the non-functional human pseudogene
Chimeric constructs combining pig GULO domains with human pseudogene sequences can identify critical functional regions
Understanding pig GULO function could inform potential therapeutic strategies targeting vitamin C metabolism
The human GULO region shows only 84% and 87% identity compared to chimpanzee and gorilla, respectively, challenging common assumptions about evolutionary relationships
This research area requires sophisticated genomic analysis techniques, including:
Comparative sequence analysis across species
Structural modeling of functional and non-functional GULO variants
Functional complementation studies
Evolutionary rate analysis of GULO sequence changes
Understanding the kinetic parameters of recombinant pig GULO is essential for comparative enzymology and optimization of experimental conditions:
Key Kinetic Parameters:
While specific pig GULO kinetic data is not provided in the search results, comparative data from rat GULO variants provide a relevant reference point:
| Parameter | Rat fGULO | Rat cGULO | Pig GULO (estimated) |
|---|---|---|---|
| Km (μM) | 53.5 ± 5.0 | 42.0 ± 6.3 | 45-55 (expected range) |
| Optimal pH | 7.0 | 6.5 | 6.5-7.0 (expected range) |
| Optimal temperature (°C) | 40 | 30 | 37-40 (expected range) |
| Cofactor | FAD | FAD | FAD |
The lower Km value for the C-terminal domain (cGULO) compared to the full-length enzyme (fGULO) suggests higher substrate affinity in the catalytic domain alone . Researchers working with pig GULO should perform detailed kinetic characterization to establish precise parameters for their specific recombinant constructs.
Steady-state kinetics using varying substrate concentrations
Determination of Km and Vmax through Lineweaver-Burk or Eadie-Hofstee plots
Inhibition studies to identify regulatory mechanisms
pH and temperature profiling to optimize reaction conditions
These kinetic studies should be conducted under standardized conditions to enable meaningful cross-species comparisons.
When working with recombinant pig GULO, researchers may encounter several challenges that require systematic troubleshooting:
Optimize codon usage for expression system
Test different promoter strengths
Evaluate different host strains/cell lines
Consider expressing the C-terminal domain instead of full-length protein, as it shows better production efficiency in bacterial systems
Adjust induction conditions (temperature, inducer concentration, duration)
Ensure FAD cofactor availability
Verify protein folding through circular dichroism or fluorescence spectroscopy
Check for inhibitory compounds in buffers
Optimize assay conditions (pH, temperature, substrate concentration)
Consider the optimal conditions observed for rat GULO variants (pH 7.0, 40°C for fGULO; pH 6.5, 30°C for cGULO)
Standardize substrate quality and preparation
Implement rigorous quality control for reagents
Include appropriate controls in each assay
Consider using multiple detection methods to cross-validate results
Optimize buffer composition
Add stabilizing agents (glycerol, reducing agents)
Evaluate storage conditions systematically
Consider protein engineering to enhance stability
By methodically addressing these issues, researchers can improve the reliability and reproducibility of their recombinant pig GULO studies.
Comparative studies of GULO from different species require careful experimental design:
Generate comparable constructs across species (full-length vs. domain-specific)
Standardize tags and fusion partners
Consider codon optimization for the chosen expression system
Include flexible linkers where appropriate for fusion proteins
Use identical expression systems for all GULO variants
Apply consistent purification protocols
Verify protein integrity through SDS-PAGE and mass spectrometry
Quantify protein concentration using multiple methods
Perform assays under identical conditions where possible
If optimal conditions differ between species, perform cross-comparison under both sets of conditions
Use consistent substrate batches and preparation methods
Include internal standards to normalize between experimental runs
Apply uniform statistical methods across all comparisons
Generate complete kinetic profiles rather than single-point measurements
Conduct thermal and pH stability profiles for all variants
Use multiple analytical techniques to confirm findings
By implementing these best practices, researchers can ensure that observed differences between pig GULO and other species' GULO enzymes reflect genuine biological variation rather than methodological inconsistencies.
Several cutting-edge technologies offer new opportunities for advancing recombinant pig GULO research:
Random mutagenesis coupled with high-throughput screening
PACE (Phage-Assisted Continuous Evolution) for rapid enzyme optimization
Computational design followed by experimental validation
Cryo-electron microscopy for high-resolution structural determination
Hydrogen-deuterium exchange mass spectrometry for dynamics analysis
AlphaFold2 and other AI-based structure prediction tools
Base editing for precise nucleotide changes without double-strand breaks
Prime editing for even more controlled genetic modifications
Tracking GULO expression heterogeneity in engineered cell populations
Correlating GULO activity with cellular phenotypes
Spatial transcriptomics to understand GULO expression patterns in tissues
These technologies could enable more sophisticated studies of GULO function, regulation, and potential applications in both basic research and biotechnological contexts.
Comparative analysis of functional pig GULO with non-functional primate GULO pseudogenes provides unique opportunities for evolutionary research:
Detailed sequence comparison reveals independent GULO exon losses in humans, chimpanzees, and gorillas
These patterns challenge certain aspects of common ancestry models
The 28,800 base human GULO region shows only 84% and 87% identity compared to chimpanzee and gorilla respectively
GULO degradation appears associated with transposable element fragments
Deletion events likely occurred via unequal recombination
Similar mechanisms may apply to other pseudogenes
GULO functionality loss appears in diverse taxonomic groups (primates, guinea pigs, some bats, passerine birds)
These patterns represent examples of convergent genetic loss
Understanding why certain species could tolerate GULO loss provides insights into dietary adaptation
Phylogenetic analysis using maximum likelihood and Bayesian methods
Molecular clock studies to date pseudogenization events
Functional complementation experiments using recombinant pig GULO
Comparative genomics across multiple species with varying GULO functionality
This research area highlights how studying functional enzymes in one species can illuminate evolutionary processes in related species where gene function has been lost.
Engineered recombinant pig GULO variants offer numerous potential applications in research and biotechnology:
Engineered GULO with enhanced catalytic efficiency or stability
Immobilized enzyme systems for continuous vitamin C production
Cell-free biocatalytic systems utilizing optimized GULO variants
Genetically modified pigs expressing enhanced GULO variants
Integration with other genetic modifications for optimized donor organs
Localized vitamin C production to improve transplant outcomes
Cell lines with controllable GULO expression
Humanized animal models with regulatable GULO activity
In vitro reconstitution of the vitamin C biosynthetic pathway
Altered substrate specificity for production of vitamin C derivatives
Temperature or pH tolerance modifications for industrial applications
Fusion proteins combining GULO with other enzymatic activities
Each of these applications would require careful protein engineering approaches, including rational design based on structural information, directed evolution for desired properties, and thorough characterization of the resulting variants.